Related Experiment Video
Updated: Oct 12, 2025

12:45
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
5.9K
Medial Inguino-Femoral Lymphadenectomy for Vulvar Cancer: An Approach to Decrease Lymphedema without Compromising
Neville F Hacker1,2, Ellen Barlow1, Stephen Morrell3
1Gynaecological Cancer Centre, Royal Hospital for Women, Sydney 2031, Australia.
Cancers
|November 27, 2021
Summary
Selective inguinal lymph node dissection can reduce lower limb lymphedema after vulvar cancer surgery. Leaving lateral lymph nodes in place when medial nodes are negative is a safe and effective approach.
Area of Science:
- Oncology
- Surgical Oncology
- Lymphedema Research
Background:
- Lower limb lymphedema is a common complication following inguinofemoral lymphadenectomy for vulvar cancer.
- The risk of lymphedema is associated with the number of lymph nodes removed.
- A hypothesis proposed that preserving lateral lymph nodes could mitigate this risk.
Purpose of the Study:
- To evaluate the safety and efficacy of a selective lymphadenectomy approach in vulvar cancer patients.
- To determine if medial infragenual lymphadenectomy alone is sufficient when medial lymph nodes are negative.
- To reduce the incidence of lower limb lymphedema without compromising oncological outcomes.
Main Methods:
- Patients with vulvar cancer, including those with medial extension, were included.
- Exclusion criteria involved tumors extending laterally, posteriorly, or anteriorly.
- Inguinal nodes were dissected and categorized into medial and lateral groups relative to the femoral artery.
Main Results:
- Data from 112 groins of 76 patients were analyzed.
- Positive lymph nodes were identified in 38.2% of cases, all with medial involvement.
- Only 6.6% of patients had positive lateral inguinal nodes, with a very low probability (0.00002) of a positive lateral node if medial nodes were negative.
Conclusions:
- Medial infragenual lymphadenectomy may be sufficient for vulvar cancer when medial lymph nodes are negative.
- This selective approach can significantly reduce the risk of lower limb lymphedema.
- The strategy appears to maintain oncological safety, potentially improving patient survival and quality of life.

